128 (2): Dagnelie PC, van Staveren WA, van den Berg H
Kauverian Editorial: Sepsis Prevention, Heart Failure Care & Clinical Innovation Interventions and their impact on Sepsis prevention at NICU Evaluation of cefepime-enmetazobactam against ESBL and AmpC -lactamase producing Gram-negative bacteria: In- vitro study Interventions in Acute Ilio-Femoral DVT 5 Years Institutional Experience Molecular diagnosis of infectious diseases Monthly Heart Failure audit report on GDMT in Heart city, January 2025 Assessment of anthropometric parameters and clinical profile as predictors for OSA severity in a tertiary care hospital in South India Acute Pulmonary Embolism, highlights of a Kauvery Post Graduate Lecture Podcast: Surgical Site Infection An Overview Video: Pathologists Role in the Diagnosis in Critical Clinical Situations A Case-Based Discussion A case series: On patients with arrhythmias Intravenous Fluid Therapy: A comprehensive review A twisted ankle tale: Closed reduction of medial subtalar dislocation in the Emergency department
The FDA's Pharmacy Compounding Advisory Committee (PCAC) is scheduled to review TB-500 in July 2026 for possible placement on the 503A Bulks List (Category 1)
Unlike oral supplements, our B12 injections deliver the vitamin directly into your bloodstream for maximum absorption and faster results
MOTS-C, a mitochondria-derived peptide drawing attention for its potential effects on insulin resistance, obesity, and osteoporosis, is also on Thursday's agenda
ALL PRODUCTS ARE NOT LABELED
